These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 31966357)

  • 1. Overexpression of galectin-4 promotes cell growth of hepatocellular carcinoma cells in vitro and in vivo.
    Chen C; Wang G; Huang X; Dong X; Chen G; Lin M; Cai Z; Zeng Y
    Int J Clin Exp Pathol; 2017; 10(10):10233-10242. PubMed ID: 31966357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectin-1 Modulates the Survival and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Sensitivity in Human Hepatocellular Carcinoma Cells.
    Li J; Sun RR; Yu ZJ; Liang H; Shen S; Kan Q
    Cancer Biother Radiopharm; 2015 Oct; 30(8):336-41. PubMed ID: 26348206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis.
    Chen S; Pu J; Bai J; Yin Y; Wu K; Wang J; Shuai X; Gao J; Tao K; Wang G; Li H
    J Exp Clin Cancer Res; 2018 Jan; 37(1):3. PubMed ID: 29316949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-1-Induced Autophagy Facilitates Cisplatin Resistance of Hepatocellular Carcinoma.
    Su YC; Davuluri GV; Chen CH; Shiau DC; Chen CC; Chen CL; Lin YS; Chang CP
    PLoS One; 2016; 11(2):e0148408. PubMed ID: 26859293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectin-9 suppresses the growth of hepatocellular carcinoma via apoptosis in vitro and in vivo.
    Fujita K; Iwama H; Sakamoto T; Okura R; Kobayashi K; Takano J; Katsura A; Tatsuta M; Maeda E; Mimura S; Nomura T; Tani J; Miyoshi H; Morishita A; Yoneyama H; Yamana Y; Himoto T; Okano K; Suzuki Y; Niki T; Hirashima M; Masaki T
    Int J Oncol; 2015; 46(6):2419-30. PubMed ID: 25823465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-1 triggers epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
    Bacigalupo ML; Manzi M; Espelt MV; Gentilini LD; Compagno D; Laderach DJ; Wolfenstein-Todel C; Rabinovich GA; Troncoso MF
    J Cell Physiol; 2015 Jun; 230(6):1298-309. PubMed ID: 25469885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
    Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
    J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel role of semaphorin 3A in the growth and progression of hepatocellular carcinoma.
    Li X; Chen Q; Yin D; Shi S; Yu L; Zhou S; Chen E; Zhou Z; Shi Y; Fan J; Zhou J; Dai Z
    Oncol Rep; 2017 Jun; 37(6):3313-3320. PubMed ID: 28498470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immature colon carcinoma transcript-1 promotes cell growth of hepatocellular carcinoma via facilitating cell cycle progression and apoptosis resistance.
    Chang W; Yu Z; Tian M; Lin X
    Oncol Rep; 2017 Dec; 38(6):3489-3496. PubMed ID: 29130100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galectin-14 promotes hepatocellular carcinoma tumor growth
    Gou L; Yang G; Ma S; Ding T; Sun L; Liu F; Huang J; Gao W
    J Biomed Res; 2023 Nov; 37(6):418-430. PubMed ID: 37977559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway.
    Zhu H; Wang J; Yin J; Lu B; Yang Q; Wan Y; Jia C
    Cell Physiol Biochem; 2018; 45(3):1121-1135. PubMed ID: 29439259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitidine chloride inhibits hepatocellular carcinoma cell growth in vivo through the suppression of the JAK1/STAT3 signaling pathway.
    Liao J; Xu T; Zheng JX; Lin JM; Cai QY; Yu DB; Peng J
    Int J Mol Med; 2013 Jul; 32(1):79-84. PubMed ID: 23613111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early growth response 3 inhibits growth of hepatocellular carcinoma cells via upregulation of Fas ligand.
    Zhang S; Xia C; Xu C; Liu J; Zhu H; Yang Y; Xu F; Zhao J; Chang Y; Zhao Q
    Int J Oncol; 2017 Mar; 50(3):805-814. PubMed ID: 28098878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up-regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway.
    Chen C; Chang YC; Liu CL; Liu TP; Chang KJ; Guo IC
    Endocr Relat Cancer; 2007 Jun; 14(2):513-29. PubMed ID: 17639064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCL2L10 inhibits growth and metastasis of hepatocellular carcinoma both in vitro and in vivo.
    Bai Y; Wang J; Han J; Xie XL; Ji CG; Yin J; Chen L; Wang CK; Jiang XY; Qi W; Jiang HQ
    Mol Carcinog; 2017 Mar; 56(3):1137-1149. PubMed ID: 27770580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the role of galectin-3 in cancer apoptosis.
    Nakahara S; Oka N; Raz A
    Apoptosis; 2005 Mar; 10(2):267-75. PubMed ID: 15843888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells.
    Kim HR; Lin HM; Biliran H; Raz A
    Cancer Res; 1999 Aug; 59(16):4148-54. PubMed ID: 10463621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Argonaute2 promotes tumor metastasis by way of up-regulating focal adhesion kinase expression in hepatocellular carcinoma.
    Cheng N; Li Y; Han ZG
    Hepatology; 2013 May; 57(5):1906-18. PubMed ID: 23258480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BMP4 promotes hepatocellular carcinoma proliferation by autophagy activation through JNK1-mediated Bcl-2 phosphorylation.
    Deng G; Zeng S; Qu Y; Luo Q; Guo C; Yin L; Han Y; Li Y; Cai C; Fu Y; Shen H
    J Exp Clin Cancer Res; 2018 Jul; 37(1):156. PubMed ID: 30012194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma.
    Hsu DK; Dowling CA; Jeng KC; Chen JT; Yang RY; Liu FT
    Int J Cancer; 1999 May; 81(4):519-26. PubMed ID: 10225438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.